N

NeuroSigma

5 employees

NeuroSigma develops and commercializes trigeminal nerve stimulation (TNS) for a variety of neurologic and psychiatric disorders.

Basic info

Industry

medical equipment manufacturing

Sectors

Biotechnology
Developer Platform
Medical

Date founded

2008

Funding rounds raised

Total raised

$5M

from 1 investors over 1 rounds

N

NeuroSigma raised $5M on December 8, 2021

Investors: KT

FAQ